Ocular Therapeutix Derivative Contract Liabilities (Quarterly) Insights

Ocular Therapeutix, Inc. (OCUL)

9.49 +0.54 (+5.97%) USD | NASDAQ | Feb 25, 16:00

9.53 +0.04 (+0.42%) After-Hours: 17:07

View Derivative Contract Liabilities (Quarterly) for OCUL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Derivative Contract Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Derivative Contract Liabilities (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Boston Scientific Corp.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
EyePoint Plc	--
Vertex Pharmaceuticals, Inc.	--